S. Kumar, “A Real World Analysis of Safety and Efficacy of Nilotinib when Used as First Line and Beyond: Retrospective Single Centre Study Representing Largest Cohort of Indian Patients Treated with Nilotinib”, Asian Pac J Cancer Biol, vol. 9, no. 2, pp. 137–147, May 2024.